Filing Details
- Accession Number:
- 0000014272-19-000044
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-02-13 16:43:23
- Reporting Period:
- 2018-04-30
- Accepted Time:
- 2019-02-13 16:43:23
- Original Submission Date:
- 2018-05-02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1360224 | C Dinesh Paliwal | Bristol-Myers Squibb Company 430 E. 29Th Street, 14 Floor New York NY 10016 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Acquisiton | 2018-04-30 | 9,540 | $52.40 | 12,935 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $52.39 to $52.40, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Due to a software error, this Form 4 is being amended to report in Column 4 and Column 5 the correct amount of securities acquired and the correct number of securities beneficially owned following the reported transaction, respectively.
Billionaire Hedge Funds
